FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055525234> ?p ?o ?g. }

• W2055525234 endingPage "1020" @default.
• W2055525234 startingPage "1008" @default.
• W2055525234 abstract "Chronic treatment with high-affinity, competitive N-methyl-D-aspartate receptor (NMDAR) antagonists can promote axonal sprouting, induce neuronal loss and exacerbate seizures associated with temporal lobe epilepsy. Whether moderate-affinity uncompetitive and NR2B subunit-selective NMDAR antagonists elicit similar responses remains largely unexplored. We directly compared the effects of distinct classes of NMDAR antagonists on electrographic seizures, axonal sprouting and neuronal survival using electrophysiological recordings and histology in hippocampal slice cultures treated chronically with vehicle, D-APV (high-affinity competitive), Ro 25-6981 or ifenprodil (NR2B-selective), or memantine (moderate-affinity uncompetitive). Granule cell layer field potential recordings revealed multiple spontaneous electrographic seizures in vehicle-treated cultures following GABA(A) receptor blockade. Compared to vehicle, seizures were dramatically reduced in cultures treated with NR2B selective antagonists and slightly increased in cultures treated with moderate-affinity uncompetitive or high-affinity competitive antagonists. In general, compared to vehicle, cultures treated with NR2B selective antagonists exhibited less sprouting of granule cell mossy fiber axons (MFS) and more granule cell layer neurons. Cultures treated with high-affinity competitive or moderate-affinity uncompetitive NMDAR antagonists showed increased MFS and fewer granule cell layer neurons. These data reveal differential effects of distinct classes of NMDAR antagonists on seizure expression, axonal sprouting and neuronal survival and suggest an association between these responses." @default.
• W2055525234 created "2016-06-24" @default.
• W2055525234 creator A5011741973 @default.
• W2055525234 creator A5059352135 @default.
• W2055525234 date "2004-12-01" @default.
• W2055525234 modified "2023-10-12" @default.
• W2055525234 title "Effects of distinct classes of N-methyl-d-aspartate receptor antagonists on seizures, axonal sprouting and neuronal loss in vitro: suppression by NR2B-selective antagonists" @default.
• W2055525234 cites W1487386905 @default.
• W2055525234 cites W1499205986 @default.
• W2055525234 cites W1594111906 @default.
• W2055525234 cites W1601370356 @default.
• W2055525234 cites W1605336512 @default.
• W2055525234 cites W16063083 @default.
• W2055525234 cites W1675918816 @default.
• W2055525234 cites W1863375292 @default.
• W2055525234 cites W1880195515 @default.
• W2055525234 cites W1975317646 @default.
• W2055525234 cites W1979406476 @default.
• W2055525234 cites W1981234599 @default.
• W2055525234 cites W1987414520 @default.
• W2055525234 cites W1988358396 @default.
• W2055525234 cites W1990912315 @default.
• W2055525234 cites W1996374928 @default.
• W2055525234 cites W1997956229 @default.
• W2055525234 cites W2003066583 @default.
• W2055525234 cites W2012586761 @default.
• W2055525234 cites W2014408809 @default.
• W2055525234 cites W2023149896 @default.
• W2055525234 cites W2024945446 @default.
• W2055525234 cites W2025302434 @default.
• W2055525234 cites W2026285134 @default.
• W2055525234 cites W2032216760 @default.
• W2055525234 cites W2032734645 @default.
• W2055525234 cites W2035562497 @default.
• W2055525234 cites W2036650593 @default.
• W2055525234 cites W2044795903 @default.
• W2055525234 cites W2048999009 @default.
• W2055525234 cites W2049511526 @default.
• W2055525234 cites W2052795247 @default.
• W2055525234 cites W2053980736 @default.
• W2055525234 cites W2059401172 @default.
• W2055525234 cites W2062513218 @default.
• W2055525234 cites W2065169750 @default.
• W2055525234 cites W2065848862 @default.
• W2055525234 cites W2072420392 @default.
• W2055525234 cites W2072465507 @default.
• W2055525234 cites W2077369265 @default.
• W2055525234 cites W2079054696 @default.
• W2055525234 cites W2080980389 @default.
• W2055525234 cites W2081070804 @default.
• W2055525234 cites W2099222699 @default.
• W2055525234 cites W2118926295 @default.
• W2055525234 cites W2121239869 @default.
• W2055525234 cites W2139374120 @default.
• W2055525234 cites W2146204489 @default.
• W2055525234 cites W2149462562 @default.
• W2055525234 cites W2151181976 @default.
• W2055525234 cites W2170085655 @default.
• W2055525234 cites W2173317214 @default.
• W2055525234 cites W2316145923 @default.
• W2055525234 doi "https://doi.org/10.1016/j.neuropharm.2004.07.036" @default.
• W2055525234 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15555635" @default.
• W2055525234 hasPublicationYear "2004" @default.
• W2055525234 type Work @default.
• W2055525234 sameAs 2055525234 @default.
• W2055525234 citedByCount "31" @default.
• W2055525234 countsByYear W20555252342012 @default.
• W2055525234 countsByYear W20555252342013 @default.
• W2055525234 countsByYear W20555252342014 @default.
• W2055525234 countsByYear W20555252342015 @default.
• W2055525234 countsByYear W20555252342016 @default.
• W2055525234 countsByYear W20555252342017 @default.
• W2055525234 countsByYear W20555252342019 @default.
• W2055525234 countsByYear W20555252342021 @default.
• W2055525234 countsByYear W20555252342022 @default.
• W2055525234 countsByYear W20555252342023 @default.
• W2055525234 crossrefType "journal-article" @default.
• W2055525234 hasAuthorship W2055525234A5011741973 @default.
• W2055525234 hasAuthorship W2055525234A5059352135 @default.
• W2055525234 hasConcept C14728290 @default.
• W2055525234 hasConcept C148762608 @default.
• W2055525234 hasConcept C150757390 @default.
• W2055525234 hasConcept C169760540 @default.
• W2055525234 hasConcept C170493617 @default.
• W2055525234 hasConcept C181199279 @default.
• W2055525234 hasConcept C185592680 @default.
• W2055525234 hasConcept C25274449 @default.
• W2055525234 hasConcept C2776464000 @default.
• W2055525234 hasConcept C2778888523 @default.
• W2055525234 hasConcept C2779484449 @default.
• W2055525234 hasConcept C2780376555 @default.
• W2055525234 hasConcept C55493867 @default.
• W2055525234 hasConcept C61174792 @default.
• W2055525234 hasConcept C67018056 @default.
• W2055525234 hasConcept C86803240 @default.
• W2055525234 hasConcept C98274493 @default.
• W2055525234 hasConceptScore W2055525234C14728290 @default.
• W2055525234 hasConceptScore W2055525234C148762608 @default.

• next